pta20250304065
Managers' transactions announcement according to article 19 MAR

QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR

Venlo (pta065/04.03.2025/22:10 UTC+1) - Announcement

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Thierry Bernard
2 Reason for the notification
a) Position/status Member of the managing body
b) Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name QIAGEN N.V.
b) LEI 54930036WK3GMCN17Z57
4 Details of the transaction(s)
a) Description of the financial instrument, type of instrument Share
  Identification code NL0015002CX3
b) Nature of the transaction Another
    Release of 105,600 Performance Stock Units based on grant made on February 28, 2020. Release of 103,400 Performance Stock Units based on grant made on February 28, 2022.Exercise Price: $0. Closing Price on February 28, 2025: $38.40. Subsequent to the grant release, receipt of 106,903 Common Shares upon net share settlement wherein a number of Common Share are withheld by the Company to cover related expenses (such as taxes and transaction costs based on share price on vesting date). Grant of 143,229 Performance Stock Units. Cancellation of 6,600 Performance Stock Units.
    Transaction linked to the exercise of share option programmes
c) Price(s) Volume(s)
  Not Quantifiable Not Quantifiable
d) Aggregated price Aggregated volume
  Not Quantifiable Not Quantifiable
e) Date of the transaction 28.02.2025 UTC+1
f) Place of the transaction Outside a trading venue

(end)

Emitter: QIAGEN N.V.
Hulsterweg 82
5912 PL Venlo
Netherlands
Contact Person: Investor Relations
Phone: +31 7735566 - 00
E-Mail: ir@qiagen.com
Website: www.qiagen.com
ISIN(s): NL0015002CX3 (Share)
Stock Exchange(s): Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate
Other Stock Exchanges: NYSE, SIX, BX Swiss
|